VAXXEL: Vaxxel raises EUR 1.2m to fund the development of its intranasal bivalent vaccine candidate against bronchiolitis and viral pneumonia
Press Release Lyon (FR) - 18 March 2022, 8:00 am CET Vaxxel , a French start-up developing vaccines against respiratory viral infections, announces it has raised €1.2 million funding to support
Kostenloser Wertpapierhandel Transgene Euronext Virpath Lyon Denis Cavert Laboratory Of The University Claude Bernard Ministry Of Higher Education
Source: finanznachrichten.de